Investing.com - Tianjin Ringpu Bio Tech reported on Wednesday third quarter earnings that beat analysts' forecasts and revenue that fell short of expectations.
Tianjin Ringpu Bio Tech announced earnings per share of ¥0.20 on revenue of ¥568.40. Analysts polled by Investing.com EPS of ¥0.18 on revenue of ¥2,007M.
Tianjin Ringpu Bio Tech 's are up 78% and is trading at ¥20.79 , still down 19.48% from its 52 week high of ¥25.82 set on Monday, January 10, 2022.
Tianjin Ringpu Bio Tech shares gained 4.53% to trade at ¥20.79 in intra-day trade the report.
Tianjin Ringpu Bio Tech follows other major Healthcare sector earnings this month
Tianjin Ringpu Bio Tech's report follows an earnings missed by Aier Eye Hospital Group on Wednesday, who reported EPS of ¥0.15 on revenue of ¥4.94B, EPS of ¥0.1722 on revenue of ¥5.7B.
Imeik had missed expectations on Wednesday with third quarter EPS of ¥1.85 on revenue of ¥604.5M, for EPS of ¥1.95 on revenue of ¥692.11M.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar